These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20211368)

  • 1. Editorial comment.
    Blok BF
    Urology; 2010 Mar; 75(3):558. PubMed ID: 20211368
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
    Haferkamp A
    Eur Urol; 2008 Jun; 53(6):1253. PubMed ID: 18343561
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment on: Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Fowler CJ
    Eur Urol; 2009 Mar; 55(3):712. PubMed ID: 18814958
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment on: Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Schurch B
    Eur Urol; 2009 Mar; 55(3):711-2. PubMed ID: 18814956
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment on: Intraprostatic and bladder-neck botulinum A toxin in treatment of males with bladder-neck dyssynergia: a pilot study.
    Michel M
    Eur Urol; 2008 Mar; 53(3):626-7. PubMed ID: 17950523
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment on: Intraprostatic and bladder-neck injection of botulinum A toxin in treatment of males with bladder-neck dyssynergia: a pilot study.
    Pickard R
    Eur Urol; 2008 Mar; 53(3):626. PubMed ID: 17950524
    [No Abstract]   [Full Text] [Related]  

  • 7. Intradetrusor botulinum toxin injections for neurogenic overactive bladder: are we there yet?
    Lemack GE
    Eur Urol; 2008 Feb; 53(2):240-1. PubMed ID: 17997019
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
    Novara G
    Eur Urol; 2009 Oct; 56(4):706-7. PubMed ID: 18472211
    [No Abstract]   [Full Text] [Related]  

  • 9. The current standing of intramural injection of botulinum neurotoxin in managing the overactive bladder.
    Drake MJ
    BJU Int; 2008 Jul; 102 Suppl 1():1. PubMed ID: 18665970
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Cartwright R; Cardozo L
    J Urol; 2007 Feb; 177(2):796-7; author reply 797. PubMed ID: 17222687
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre.
    Wyndaele JJ
    Eur Urol; 2008 May; 53(5):1019-20. PubMed ID: 17950988
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2008 Feb; 101(4):515-6; author reply 516-7. PubMed ID: 18234066
    [No Abstract]   [Full Text] [Related]  

  • 13. The case for bladder botulinum toxin application.
    Kim DK; Thomas CA; Smith C; Chancellor MB
    Urol Clin North Am; 2006 Nov; 33(4):503-10, ix. PubMed ID: 17011386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity.
    Sahai A; Dowson C; Khan MS; Dasgupta P;
    Urology; 2010 Mar; 75(3):552-8. PubMed ID: 20035984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second-line management of idiopathic overactive bladder: what is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?
    Chapple C; De Ridder D
    BJU Int; 2009 Nov; 104(9):1188-90. PubMed ID: 19681899
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder].
    Bentaleb Y; Castel-Lacanal E; Sallusto F; De Boissezon X; Malavaud B; Marque P; Rischmann P; Gamé X
    Prog Urol; 2008 Jul; 18(7):449-55. PubMed ID: 18602606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
    Antunes AA; Srougi M; Coelho RF; de Campos Freire G
    Nat Clin Pract Urol; 2007 Mar; 4(3):155-60. PubMed ID: 17347660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment on: Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
    Novara G
    Eur Urol; 2008 Mar; 53(3):618-9. PubMed ID: 17804151
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment on: Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.
    Gratzke C; Hedlund P
    Eur Urol; 2009 Jun; 55(6):1448-9. PubMed ID: 19054607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.